Trial of Covid-19 drug given via inhaler 'very promising', say scientists

Researchers say SNG001 can reduce need for ventilation and improve survival chances

• Coronavirus - latest updates
• See all our coronavirus coverage

Trials of an experimental drug inhaled by patients have found a significant reduction in hospital patients with Covid-19 needing to be put on a ventilator or dying from the disease, according to researchers

The drug, called SNG001, is delivered via an inhaler and is based on interferon beta, a protein produced naturally in the body that plays an important role in coordinating the body's antiviral response.